HLA-allele matched unrelated donors compared to HLA-matched sibling donors: Role of cell source and disease risk category

Biology of Blood and Marrow Transplantation

Volumn 16, Issue 10, 2010, Pages 1382-1387

  Woolfrey, Ann ^a,b   Lee, Stephanie J ^a,c   Gooley, Ted A ^a   Malkki, Mari ^a   Martin, Paul J ^a,c   Pagel, John M ^a,c   Hansen, John A ^a,c   Petersdorf, Effie ^a,c  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Blood transplant; Bone marrow transplant; HLA matched; Matched sibling donor; Unrelated donor

Indexed keywords

CYCLOSPORIN A; HLA A ANTIGEN; HLA B ANTIGEN; HLA C ANTIGEN; HLA DQB1 ANTIGEN; HLA DR ANTIGEN; METHOTREXATE;

ACUTE GRAFT VERSUS HOST DISEASE; ACUTE LEUKEMIA; ALLELE; ARTICLE; BLAST CELL CRISIS; BONE MARROW TRANSPLANTATION; CANCER MORTALITY; CANCER RELAPSE; CANCER SURVIVAL; CHRONIC GRAFT VERSUS HOST DISEASE; CHRONIC MYELOID LEUKEMIA; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DONOR; FEMALE; GRAFT VERSUS HOST REACTION; HEMATOLOGIC MALIGNANCY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA MATCHING; HUMAN; LEUKEMIA RELAPSE; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MYELOABLATIVE CONDITIONING; MYELODYSPLASTIC SYNDROME; MYELOFIBROSIS; OVERALL SURVIVAL; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; RECURRENT DISEASE; REFRACTORY ANEMIA WITH EXCESS BLASTS; REFRACTORY ANEMIA WITH EXCESS BLASTS IN TRANSFORMATION; REFRACTORY ANEMIA WITH RINGED SIDEROBLASTS; RETROSPECTIVE STUDY; SIBLING; T CELL DEPLETION;

ADOLESCENT; ADULT; AGED; BONE MARROW TRANSPLANTATION; CHILD; CHILD, PRESCHOOL; DISEASE-FREE SURVIVAL; FEMALE; GRAFT VS HOST DISEASE; HEMATOLOGIC NEOPLASMS; HLA ANTIGENS; HUMANS; INFANT; KAPLAN-MEIER ESTIMATE; LIVING DONORS; MALE; MIDDLE AGED; MYELOABLATIVE AGONISTS; ORGAN SPECIFICITY; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK; SIBLINGS; TRANSPLANTATION CONDITIONING; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77956296548     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2010.03.024     Document Type: Article

References (16)

1. Petersdorf E.W., Anasetti C., Martin P.J., et al. Limits of HLA mismatching in unrelated hematopoietic cell transplantation. Blood 2004, 104:2976-2980.
2. Lee S.J., Klein J., Haagenson M., et al. High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation. Blood 2007, 110:4576-4583.
3. Yakoub-Agha I., Mesnil F., Kuentz M., et al. Allogeneic marrow stem-cell transplantation from human leukocyte antigen-identical siblings versus human leukocyte antigen-allelic-matched unrelated donors (10/10) in patients with standard-risk hematologic malignancy: a prospective study from the French Society of Bone Marrow Transplantation and Cell Therapy. J Clin Oncol 2006, 24:5695-5702.
4. Ringden O., Pavletic S.Z., Anasetti C., et al. The granft-versus-leukemia effect using matched unrelated donors is not superior to HLA-identical siblings for hematopoietic stem cell transplantation. Blood 2009, 113:3110-3118.
5. Hansen J.A., Mickelson E.M., Choo S.Y., et al. Clinical bone marrow transplantation: donor selection and recipient monitoring. Manual of Clinical Laboratory Immunology 1992, 850-866. American Society for Microbiology, Washington, DC. N.R. Rose, E.C. De Macario, J.L. Fahey, H. Friedman, G.M. Penn (Eds.).
6. Dupont B., Yang S.Y. Histocompatibility. Bone Marrow Transplantation 1994, 22-40. Blackwell Scientific Publications, Boston, MA. S.J. Forman, K.G. Blume, E.D. Thomas (Eds.).
7. Petersdorf E.W., Smith A.G., Mickelson E.M., Martin P.J., Hansen J.A. Ten HLA-DR4 alleles defined by sequence polymorphisms within the DRB1 first domain. Immunogenetics 1991, 33:267-275.
8. Anasetti C., Amos D., Beatty P.G., et al. Effect of HLA compatibility on engraftment of bone marrow transplants in patients with leukemia or lymphoma. N Engl J Med 1989, 320:197-204.
9. Wheatley K., Burnett A.K., Goldstone A.H., et al. A simple, robust, validated and highly predictive index for the determination of risk-directed therapy in acute myeloid leukaemia derived from the MRC AML 10 trial. United Kingdom Medical Research Council's Adult and Childhood Leukaemia Working Parties. Br J Haematol 1999, 107:69-79.
10. Stanulla M., Cario G., Meissner B., et al. Integrating molecular information into treatment of childhood acute lymphoblastic leukemia-a perspective from the BFM Study Group (Review). Blood Cells Mol Dis 2007, 39:160-163.
11. Kaplan E.L., Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958, 53:457-481.
12. Bensinger W.I., Martin P.J., Storer B., et al. Transplantation of bone marrow as compared with peripheral blood cells from HLA-identical relatives in patients with hematologic cancers. N Engl J Med 2001, 344:175-181.
13. Vigorito A.C., Azevedo W.M., Marques J.F., et al. A randomised, prospective comparison of allogeneic bone marrow and peripheral blood progenitor cell transplantation in the treatment of haematological malignancies. Bone Marrow Transplant 1998, 22:1145-1151.
14. Flomenberg N., Baxter-Lowe L.A., Confer D., et al. Impact of HLA class I and class II high resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplant outcome. Blood 2004, 104:1923-1930.
15. Bray R.A., Hurley C.K., Kamani N.R., et al. National Marrow Donor Program HLA matching guidelines for unrelated adult hematopoietic cell transplants. Biol Blood Marrow Transplant 2008, 14:45-53.
16. Ottinger H.D., Ferencik S., Beelen D.W., et al. Hematopoietic stem cell transplantation: contrasting the outcome of transplantations from HLA-identical siblings, partially HLA-mismatched related donors, and HLA-matched unrelated donors. Blood 2003, 102:1131-1137.